慢性阻塞性肺疾病患者医院焦虑抑郁量表的心理测量学特性：系统评价方案

Psychometric Properties of the Hospital Anxiety and Depression Scale in Individuals With Chronic Obstructive Pulmonary Disease: Protocol for a Systematic Review.

作者信息

Nikolovski Aleksandra, Gamgoum Lara, Deol Arshpreet, Quilichini Shea, Kazemir Ethan, Rhodenizer Jonathan, Oliveira Ana, Brooks Dina, Alsubheen Sanaa

机构信息

School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.

West Park Healthcare Centre, Toronto, ON, Canada.

出版信息

JMIR Res Protoc. 2022 Sep 22;11(9):e37854. doi: 10.2196/37854.

DOI:10.2196/37854

PMID:36136379

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9539646/

Abstract

BACKGROUND

In individuals with chronic obstructive pulmonary disease (COPD), anxiety and depression contribute to increased mortality and exacerbations, decreased physical functioning, and deteriorated health-related quality of life. The Hospital Anxiety and Depression Scale (HADS) is a patient-reported tool developed to measure symptoms of anxiety and depression in clinical settings. The HADS has been frequently used with individuals with COPD; however, its measurement properties lack critical appraisal in this population.

OBJECTIVE

This review aims to summarize and critically appraise the validity, reliability, and responsiveness of the HADS in individuals with COPD.

METHODS

Five electronic databases (MEDLINE, Embase, Scopus, PsychINFO, and Web of Science) will be systematically searched. Articles will be included if they assessed the measurement properties of the HADS in COPD; were published in a peer-reviewed journal; and were written in English. The COSMIN (Consensus-based Standards for the Selection of Health Measurement Instruments) guidelines will be used to assess the methodological quality and level of evidence in the selected studies.

RESULTS

To date, 12 articles met the inclusion criteria and will be included in the systematic review. The results of the psychometric properties of HADS will be qualitatively summarized and compared against the criteria for good measurement properties. The overall quality of evidence will be graded using the modified Grading of Recommendations, Assessment, Development and Evaluation approach. We expect to complete the systematic review by December 2022.

CONCLUSIONS

This systematic review will be the first to evaluate the psychometric properties of the HADS in individuals with COPD. Given the negative impact of anxiety and depression on physical functioning and health-related quality of life, this systematic review provides an opportunity to use the HADS as a validated measurement tool for the assessment and treatment of anxiety and depression in individuals with COPD.

TRIAL REGISTRATION

PROSPERO CRD42022302064; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=302064.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/37854.

摘要

背景

在慢性阻塞性肺疾病（COPD）患者中，焦虑和抑郁会导致死亡率增加、病情加重、身体功能下降以及健康相关生活质量恶化。医院焦虑抑郁量表（HADS）是一种患者报告的工具，旨在测量临床环境中的焦虑和抑郁症状。HADS已被频繁用于COPD患者；然而，其测量特性在该人群中缺乏关键评估。

目的

本综述旨在总结并批判性评价HADS在COPD患者中的有效性、可靠性和反应性。

方法

将系统检索五个电子数据库（MEDLINE、Embase、Scopus、PsychINFO和Web of Science）。如果文章评估了HADS在COPD中的测量特性；发表在同行评审期刊上；并且用英文撰写，则将其纳入。将使用COSMIN（基于共识的健康测量工具选择标准）指南来评估所选研究的方法学质量和证据水平。